Global Companion Diagnostic Technologies Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Immunohistochemistry
  • 1.2.3 Molecular Diagnostics
• 1.3 Market by Application
  • 1.3.1 Global Companion Diagnostic Technologies Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Oncology
  • 1.3.3 Cardiovascular
  • 1.3.4 Central Nervous System
  • 1.3.5 Auto immune & Inflammation
  • 1.3.6 Virology
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Companion Diagnostic Technologies Market Perspective (2016-2027)
• 2.2 Companion Diagnostic Technologies Growth Trends by Regions
  • 2.2.1 Companion Diagnostic Technologies Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Companion Diagnostic Technologies Historic Market Share by Regions (2016-2021)
  • 2.2.3 Companion Diagnostic Technologies Forecasted Market Size by Regions (2022-2027)
• 2.3 Companion Diagnostic Technologies Industry Dynamic
  • 2.3.1 Companion Diagnostic Technologies Market Trends
  • 2.3.2 Companion Diagnostic Technologies Market Drivers
  • 2.3.3 Companion Diagnostic Technologies Market Challenges
  • 2.3.4 Companion Diagnostic Technologies Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Companion Diagnostic Technologies Players by Revenue
  • 3.1.1 Global Top Companion Diagnostic Technologies Players by Revenue (2016-2021)
  • 3.1.2 Global Companion Diagnostic Technologies Revenue Market Share by Players (2016-2021)
• 3.2 Global Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Companion Diagnostic Technologies Revenue
• 3.4 Global Companion Diagnostic Technologies Market Concentration Ratio
  • 3.4.1 Global Companion Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Technologies Revenue in 2020
• 3.5 Companion Diagnostic Technologies Key Players Head office and Area Served
• 3.6 Key Players Companion Diagnostic Technologies Product Solution and Service
• 3.7 Date of Enter into Companion Diagnostic Technologies Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Technologies Breakdown Data by Type

• 4.1 Global Companion Diagnostic Technologies Historic Market Size by Type (2016-2021)
• 4.2 Global Companion Diagnostic Technologies Forecasted Market Size by Type (2022-2027)

5 Companion Diagnostic Technologies Breakdown Data by Application

• 5.1 Global Companion Diagnostic Technologies Historic Market Size by Application (2016-2021)
• 5.2 Global Companion Diagnostic Technologies Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Companion Diagnostic Technologies Market Size (2016-2027)
• 6.2 North America Companion Diagnostic Technologies Market Size by Type
  • 6.2.1 North America Companion Diagnostic Technologies Market Size by Type (2016-2021)
  • 6.2.2 North America Companion Diagnostic Technologies Market Size by Type (2022-2027)
  • 6.2.3 North America Companion Diagnostic Technologies Market Size by Type (2016-2027)
• 6.3 North America Companion Diagnostic Technologies Market Size by Application
  • 6.3.1 North America Companion Diagnostic Technologies Market Size by Application (2016-2021)
  • 6.3.2 North America Companion Diagnostic Technologies Market Size by Application (2022-2027)
  • 6.3.3 North America Companion Diagnostic Technologies Market Size by Application (2016-2027)
• 6.4 North America Companion Diagnostic Technologies Market Size by Country
  • 6.4.1 North America Companion Diagnostic Technologies Market Size by Country (2016-2021)
  • 6.4.2 North America Companion Diagnostic Technologies Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Companion Diagnostic Technologies Market Size (2016-2027)
• 7.2 Europe Companion Diagnostic Technologies Market Size by Type
  • 7.2.1 Europe Companion Diagnostic Technologies Market Size by Type (2016-2021)
  • 7.2.2 Europe Companion Diagnostic Technologies Market Size by Type (2022-2027)
  • 7.2.3 Europe Companion Diagnostic Technologies Market Size by Type (2016-2027)
• 7.3 Europe Companion Diagnostic Technologies Market Size by Application
  • 7.3.1 Europe Companion Diagnostic Technologies Market Size by Application (2016-2021)
  • 7.3.2 Europe Companion Diagnostic Technologies Market Size by Application (2022-2027)
  • 7.3.3 Europe Companion Diagnostic Technologies Market Size by Application (2016-2027)
• 7.4 Europe Companion Diagnostic Technologies Market Size by Country
  • 7.4.1 Europe Companion Diagnostic Technologies Market Size by Country (2016-2021)
  • 7.4.2 Europe Companion Diagnostic Technologies Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Companion Diagnostic Technologies Market Size (2016-2027)
• 8.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type
  • 8.2.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application
  • 8.3.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Companion Diagnostic Technologies Market Size by Region
  • 8.4.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Companion Diagnostic Technologies Market Size (2016-2027)
• 9.2 Latin America Companion Diagnostic Technologies Market Size by Type
  • 9.2.1 Latin America Companion Diagnostic Technologies Market Size by Type (2016-2021)
  • 9.2.2 Latin America Companion Diagnostic Technologies Market Size by Type (2022-2027)
  • 9.2.3 Latin America Companion Diagnostic Technologies Market Size by Type (2016-2027)
• 9.3 Latin America Companion Diagnostic Technologies Market Size by Application
  • 9.3.1 Latin America Companion Diagnostic Technologies Market Size by Application (2016-2021)
  • 9.3.2 Latin America Companion Diagnostic Technologies Market Size by Application (2022-2027)
  • 9.3.3 Latin America Companion Diagnostic Technologies Market Size by Application (2016-2027)
• 9.4 Latin America Companion Diagnostic Technologies Market Size by Country
  • 9.4.1 Latin America Companion Diagnostic Technologies Market Size by Country (2016-2021)
  • 9.4.2 Latin America Companion Diagnostic Technologies Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Companion Diagnostic Technologies Market Size (2016-2027)
• 10.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type
  • 10.2.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application
  • 10.3.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Companion Diagnostic Technologies Market Size by Country
  • 10.4.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Dako (Agilent Technologies)
  • 11.1.1 Dako (Agilent Technologies) Company Details
  • 11.1.2 Dako (Agilent Technologies) Business Overview
  • 11.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Introduction
  • 11.1.4 Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.1.5 Dako (Agilent Technologies) Recent Development
• 11.2 Qiagen
  • 11.2.1 Qiagen Company Details
  • 11.2.2 Qiagen Business Overview
  • 11.2.3 Qiagen Companion Diagnostic Technologies Introduction
  • 11.2.4 Qiagen Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.2.5 Qiagen Recent Development
• 11.3 Roche
  • 11.3.1 Roche Company Details
  • 11.3.2 Roche Business Overview
  • 11.3.3 Roche Companion Diagnostic Technologies Introduction
  • 11.3.4 Roche Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.3.5 Roche Recent Development
• 11.4 Abbott Laboratories
  • 11.4.1 Abbott Laboratories Company Details
  • 11.4.2 Abbott Laboratories Business Overview
  • 11.4.3 Abbott Laboratories Companion Diagnostic Technologies Introduction
  • 11.4.4 Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.4.5 Abbott Laboratories Recent Development
• 11.5 Thermo Fisher Scientific
  • 11.5.1 Thermo Fisher Scientific Company Details
  • 11.5.2 Thermo Fisher Scientific Business Overview
  • 11.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Introduction
  • 11.5.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.5.5 Thermo Fisher Scientific Recent Development
• 11.6 bioMerieux
  • 11.6.1 bioMerieux Company Details
  • 11.6.2 bioMerieux Business Overview
  • 11.6.3 bioMerieux Companion Diagnostic Technologies Introduction
  • 11.6.4 bioMerieux Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.6.5 bioMerieux Recent Development
• 11.7 Myriad Genetics
  • 11.7.1 Myriad Genetics Company Details
  • 11.7.2 Myriad Genetics Business Overview
  • 11.7.3 Myriad Genetics Companion Diagnostic Technologies Introduction
  • 11.7.4 Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.7.5 Myriad Genetics Recent Development
• 11.8 Resonance Health Ltd.
  • 11.8.1 Resonance Health Ltd. Company Details
  • 11.8.2 Resonance Health Ltd. Business Overview
  • 11.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Introduction
  • 11.8.4 Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.8.5 Resonance Health Ltd. Recent Development
• 11.9 Leica Microsystems
  • 11.9.1 Leica Microsystems Company Details
  • 11.9.2 Leica Microsystems Business Overview
  • 11.9.3 Leica Microsystems Companion Diagnostic Technologies Introduction
  • 11.9.4 Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.9.5 Leica Microsystems Recent Development
• 11.10 Danaher
  • 11.10.1 Danaher Company Details
  • 11.10.2 Danaher Business Overview
  • 11.10.3 Danaher Companion Diagnostic Technologies Introduction
  • 11.10.4 Danaher Revenue in Companion Diagnostic Technologies Business (2016-2021)
  • 11.10.5 Danaher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer